- , Thursday, February 5, 2004 12 AM
The Food and Drug Administration is asking the makers of prescription drugs to shun the obfuscation, so to speak, by proposing revisions of its regulations on advertising directly to consumers. The
proposals encourage the ads to describe significant risks the drugs may pose in language that is clearer and easier for patients to understand.
Read the whole story at »